<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Market Newsdesk</provider_name><provider_url>https://www.marketnewsdesk.com</provider_url><author_name>Newsdesk</author_name><author_url>https://www.marketnewsdesk.com/index.php/author/newsdesk/</author_url><title>Annual General Meeting 2023 - Market Newsdesk</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="2ZL5N53POA"&gt;&lt;a href="https://www.marketnewsdesk.com/index.php/annual-general-meeting-2023/"&gt;Annual General Meeting 2023&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.marketnewsdesk.com/index.php/annual-general-meeting-2023/embed/#?secret=2ZL5N53POA" width="600" height="338" title="&#x201C;Annual General Meeting 2023&#x201D; &#x2014; Market Newsdesk" data-secret="2ZL5N53POA" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.marketnewsdesk.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland&#xA0;&#x2013;&#xA0; June 8 , 202 3 &#xA0;&#x2013;&#xA0;ObsEva SA&#xA0;(SIX: OBSN), a biopharmaceutical company developing novel therapies for women&#x2019;s health, today published the invitation to its 2023 Annual General Meeting of Shareholders to be held on&#xA0;June 29, 2023,&#xA0;at&#xA0;10:30 CEST&#xA0;at the company&#x2019;s offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228&#xA0;Plan-les-Ouates, Switzerland. The agenda of the meeting will be as follows: 1&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Approval of the Management Report, the Statutory Financial Statements and theConsolidated Financial Statements for Fiscal Year 2022 The Board of Directors proposes that the management report, the statutory financial statements and the consolidated financial statements of ObsEva SA for fiscal year 2022 be approved. 2&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Discharge of Liability &hellip; Continue reading ""</description><thumbnail_url>https://www.globenewswire.com/newsroom/ti?nf=MTAwMDgyNDEwNSM0MDE1NjQ2OTcjMjAwMDYwNQ==</thumbnail_url></oembed>
